{"cmr":"kr-cm-kg/KOSPI/069620","since":null,"total":68,"cursor":0,"limit":50,"next_cursor":50,"events":[{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-11-04","event_type":"results","title":"영업(잠정)실적(공정공시)","reference":"20261104800041","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261104800041","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wevyaAubnCA5Stotp0xMh9YgjOG6hUkEYzi30wta4eH1ALZJNDIMsSB4NZ7h687-ei4iJD1KgrGDfby8BJIzCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-11-02","event_type":"corporate_news","title":"불성실공시법인지정예고","reference":"20261102800894","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261102800894","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 유가증권시장본부; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"MEwaxrsydQxi-D4q_E-Fv8gO9RVUqDYK5Svyiarvz9sVAd2vpa2aSnoAIW482ZVVix1UYBvGuOaWrzzdRPF0Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-11-02","event_type":"corporate_news","title":"단일판매ㆍ공급계약해지","reference":"20261102800892","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261102800892","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vrAtBJoPYN17wqECEVMQzDsduqhiyWlnOWS2Lv96E5SN6VjowiTjhUL1p-MfAo2BDpjmeP-732pvP-SIekPtCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-09-09","event_type":"agm_egm","title":"임시주주총회결과","reference":"20260909800396","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260909800396","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9X0zsg1jqs4VrfAiW33IlTuK8OG7ZmnL1Nd0Zfs_IBvA-u85ga47QkHENHejxhz2TCbeULI-QbIXmaJaUFSbCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-09-09","event_type":"corporate_news","title":"독립이사의선임ㆍ해임또는중도퇴임에관한신고","reference":"20260909000373","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260909000373","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"v5kGfteXQWa7HJeZH7MMNeHKpWBP3d-ZMmNoEBWGlvS4dFCl6nkDIx_KE5nVQQNy8aN9gFd-aWAGv-Q9nExVAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-09-04","event_type":"corporate_news","title":"타인에대한채무보증결정","reference":"20260904800640","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260904800640","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"c6pIAxePC-sUoXyVJuiL0nF0VYDR-CCffoaNQMxBNykfPUlfXqrLOjvhPWWEm-sPlLabgIxR9zVEyMaL6rqiAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-09-02","event_type":"corporate_news","title":"소송등의제기ㆍ신청(일정금액이상의청구)","reference":"20260902800508","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260902800508","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dTJObxkfj6QDsp3ABScFwyeVFf6A9f59n7TdBtd05gsJsVQngEKYLZv6THUy7hz6FjspH3jBdc_taOEq7lVrCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-08-25","event_type":"agm_egm","title":"주주총회소집공고","reference":"20260825000278","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260825000278","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"L7rmv40ElTziTvv2J0rfD_P-eEP54D_ZgURAh-D1jEOEEHni1GXwt5CouGh4T8aE9MUDDe7MiT5BjEBAYkzHDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-08-25","event_type":"corporate_news","title":"의결권대리행사권유참고서류","reference":"20260825000279","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260825000279","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1PcuDsi2muAh1P2f9uCGMxM9jErL_TrhY6GTVnSHT77vZB37gIj8Or2-r0k3-yAGjoJ4palMYS5LyvyLAPkuCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-08-21","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등소유상황보고서","reference":"20260821000287","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260821000287","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 국민연금공단; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ED4igxDcLqNbRGyADZkEBctK9h13cVTVvVv2vOqObVH7I0doLeCrc9hLDiq2a6dElYhPwUx_stmQxMPdJIBdAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-08-14","event_type":"results","title":"반기보고서 (2026.06)","reference":"20260814002515","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814002515","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vI-lxgBhCvZID_Fz3VcEpnAZgtIWj23liYSw2d1x0pbBrgqd6pgcopfE2mkRoJZ-2QLYypDLOxrTfMwYsTsHCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-07-29","event_type":"results","title":"영업(잠정)실적(공정공시)","reference":"20260729800126","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260729800126","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JQzWdhYn8o6cwk1hK0Rx57eAiBAO9zqI46dug_RU4P450n4sTCCqPlr9J7NiiXMs-mriP0sgfI0tJ6yVETgvAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-07-28","event_type":"agm_egm","title":"주주총회소집결의","reference":"20260728800837","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260728800837","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"9M6ODA0sJuXsx3z9MHKK6pZX3k7TBO3BOnfK_0rmPdhIFyR1tjcmgaVKeDdvim2xuoXUmj-Ye8higwjL30XpAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-07-28","event_type":"corporate_news","title":"주주명부폐쇄기간또는기준일설정","reference":"20260728800813","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260728800813","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GmjaiJ8CMKKs06veFhPcML638kYrVzz8_C2hNCSzMW3qV3lujp1MFM7ivyg1Ocae5hk1CiNKLhr-mSxOFXRNAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-07-10","event_type":"corporate_news","title":"투자판단관련주요경영사항              (펙수클루정(Fexuclue)의 적응증 추가 국내 3상 임상시험계획(IND) 승인(미란성 위식도역류질환 치료 후 유지요법))","reference":"20260710800819","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260710800819","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"imFDiYSKQdu31P4OPvxXbe1FYTbkrOd2WddyLqX0p7UU_RKDtviLboZlNO_C-r_5mUPYOmqFEpEURcJZI_p9BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-07-07","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등소유상황보고서","reference":"20260707000328","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260707000328","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 국민연금공단; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"KoXrViT_g-P7s_utSp1bYm2EoRfA-Fh8LXsD25n32dI77LJ0kj_O0CTucbx-5GCe2md4DG9xE81w6S6lrPE9CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-06-30","event_type":"corporate_news","title":"[기재정정]신규시설투자등","reference":"20260630801610","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260630801610","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wgh6QybI3yizOH7vLi81XxTQw0X4AE0GMTB15XTn7XbgwMU8c0xdkVu-sj-14SzhekT0jGsITGERQeZck0neCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-06-30","event_type":"regulatory_filing","title":"지속가능경영보고서등관련사항(자율공시)","reference":"20260630801262","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260630801262","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XEvCjqJr4PZkC2NzeYU7-Oi4z5Y9Zj8mIKjdSfO6iWPGkWHFxNCgRTTvZILkAdvBQhY1L7FWE1Ajqs0SrmC5AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-06-26","event_type":"corporate_news","title":"단일판매ㆍ공급계약체결","reference":"20260626800586","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260626800586","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"S6kbtRWmIuSA9iiYnYHe_WrDj85q5Si8D1tMbAsJ8CyyACKv1G8NNKc7_n5STUpzRMbxvPr88tjZ83Bkdwn3Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-06-23","event_type":"corporate_news","title":"투자판단관련주요경영사항              (펙수클루정(Fexuclue)의 적응증 추가 3상 임상시험계획(IND) 승인(위궤양의 치료 요법))","reference":"20260623800356","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260623800356","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ThwL2qA-WfRDPT-tXWd4l7sEzvo1DGO8-RWUYkByBEVNe1Nq5clMbIDK8RdYFDaofmNJmNhv_Gj-plSX7fBRAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-06-01","event_type":"regulatory_filing","title":"기업지배구조보고서공시","reference":"20260601801021","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260601801021","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZKslt-9DUznjWAdM4fqMUtQl9mAZjdvyZ5mA70Kjowz0MNchUqRuIcQmTVSYWEwa-Mal2P1chT50lrWJMEQWBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-26","event_type":"corporate_news","title":"투자판단관련주요경영사항              (엔블로젬(Envlozem)의 국내 품목허가 신청)","reference":"20260526800857","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260526800857","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gwhEEQ28ihg2uEabSkLcwsIrCZhyJujZH0fEkQz0OwFM7QlKknoWXMi1XHdJn2uOmLL0DuvMabgGJKxbmkvmCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-26","event_type":"corporate_news","title":"투자판단관련주요경영사항              (엔블로정(Envlo) 0.3mg 멕시코 품목허가 승인)","reference":"20260526800257","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260526800257","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cZHXvjmCNgx0grSZMbS7xhLEpan0rL3HYRqRmSf4rL4K1QVuxGB_vC3RsmXMAKuZ0PpEtMz7MuuAkoJdMQNtDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-21","event_type":"corporate_news","title":"투자판단관련주요경영사항              (비만치료용 세마글루타이드(4주 장기지속형 주사제) 기술도입 계약 체결)","reference":"20260521800989","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260521800989","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-14rMiIRdxWgqnZW2kDaSios46UnBBk7nspIGXZVvV-hi8TlhL88bfi8XP8ykZAeLUTKCXa3UCe4udO1rvcEBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-20","event_type":"corporate_news","title":"[기재정정]투자판단관련주요경영사항              (mRNA 기반 Epigenetic Reprogramming of Aging (ERA) 기술이전 계약 지위 승계)","reference":"20260520800756","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260520800756","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4Fh0d-6GbAY6KbKH0nsCxv-eYCNKiEveFEMtUjc_qXIradJeSaQJBm2uQOoOIBG1xkp-SNoEbo2GtkCJqlwRCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-15","event_type":"results","title":"분기보고서 (2026.03)","reference":"20260515001560","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515001560","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ckVWNeroyZCd9XyHiUbCLtEI6t7RegjAe-ENdhKew_wv3Gvi25Ym9V7C8tr4onlO7FefnqvXn00iVmSKVlmoCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-12","event_type":"corporate_news","title":"투자판단관련주요경영사항              (INV008(15PGDH 저해제) 기술도입 계약 체결)","reference":"20260512800959","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260512800959","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"d-Jejdziu0RTFsm4qnRzz9MCdl7ItvqDRRNUDOseqvAGE_SGLaElUzIXG37xCzxJssctlmO1AG_y8b3AluKAAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-12","event_type":"results","title":"영업(잠정)실적(공정공시)","reference":"20260512800575","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260512800575","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"LCq88hXQgnfKBZJy7JH7N9zwV6aEof_vY6cu2EQJ417NiRveVJyrwms1Xb1UMemwuUqdQWBAncPj-9ka2PbPDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-05-07","event_type":"corporate_news","title":"투자판단관련주요경영사항              (mRNA 기반 Epigenetic Reprogramming of Aging (ERA) 기술이전 계약 지위 승계)","reference":"20260507800785","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260507800785","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5ceZQCu8f4ZUb5MoDFExc9Vo1NVuMplBfYZZ4xY6keBimdui0ejZl7ssGri5_lT3tAFd0L33sTgJ7uxY_Zx1CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-04-30","event_type":"corporate_news","title":"투자판단관련주요경영사항              (펙수클루정(Fexuclue)의 적응증 추가 국내 품목허가 승인(헬리코박터파일로리 제균을 위한 항생제 병용요법))","reference":"20260430801101","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260430801101","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BhtaMalM9IqqNQ95JLa0saSJ4dRYjuLjoLQH57h4vX3EygCqktQl2b2dsMLyOnohgmUGxUUfuF7H_4fUQJl-DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-04-10","event_type":"corporate_news","title":"투자판단관련주요경영사항","reference":"20260410800519","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260410800519","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"A6x1nypbKwOVA2ok-bkCGdvUVU74M3u0K7AvxPRBGSTnUhuIRuTMiIItGmJ6p4xMVRWGxgFnHN8Q8PS2ehlGCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-27","event_type":"corporate_news","title":"독립이사의선임ㆍ해임또는중도퇴임에관한신고","reference":"20260326001518","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260326001518","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"loKynANFN6IqvtaAwKz6KP5V82XmrsweKGYw0rjlvkmDvgT--q3aZMPFWC-wY3_5Cotyr4hETdQCrbOvvmsCDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-27","event_type":"major_holder","title":"주식등의대량보유상황보고서(일반)","reference":"20260326001509","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260326001509","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"J0f8ml15pBQtU2rZLM37F8_ztguMyeHed0eKaRP5rPk5y9SyOQkMkuUXUz8H7ETPS3SQ0jCaBsTM7Gl_vV6HAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-26","event_type":"agm_egm","title":"정기주주총회결과","reference":"20260326803214","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260326803214","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_RZvIdIBWwjPF8bdRG4rKpZc579gBTu4Yz_zOOhh6Jof7Ke1xw0j2REgOBRFXkhZ7cdL6nx9PxRQ97fhsTbeAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-26","event_type":"corporate_news","title":"최대주주등소유주식변동신고서","reference":"20260326803284","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260326803284","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"02jE2Lpj1Tst0aHsW1PwUhzaN0IUQ4xRXer3NJZuknzNgJaFaUAWhw43P_xvih3dbEw1WUJcaml2IujZE47XDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-25","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등소유상황보고서","reference":"20260325000954","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260325000954","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 국민연금공단; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XSsNIiWzCQOSZdPoi5K2D043n5yXZesBksEaGu4Tv32UPCX7YT5U0mReVTHSzS_rHw3m5y6Obrc7yvjH9S_7DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-18","event_type":"results","title":"사업보고서 (2025.12)","reference":"20260318001528","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001528","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 연","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iru_r5m-Vk0knH7ZmGatV7y4Bfu5inJHqVJyMOh5FSc4qWnS_GcGXBaAE6R7pmquRfsmPI07_fUD3orZYCnTBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-16","event_type":"corporate_news","title":"공정거래자율준수프로그램운영현황(안내공시)","reference":"20260316800242","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260316800242","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"boWnUdJOcTTd3KyT81F9ruaQtS5N8lMrUHc22xrdkNFyB1I1tHVFFihl8qJ35U0AE0ufFkbxtthZb1Lnad0rAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-09","event_type":"regulatory_filing","title":"감사보고서제출","reference":"20260309801208","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260309801208","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"kh_ULU2cvxy9XK7WJ72WfKX00ZH4lEnXfVfuBBpdxtQQxMhqlqE2KceY-XHykeLUoegMm6j9xS9VIKJQ8fzHCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-03-05","event_type":"corporate_news","title":"투자판단관련주요경영사항","reference":"20260305801764","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260305801764","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aXCD1Ylx4hJbROraTSB3q1mgdRgWXOg9Nnp0K_ibXT_pPcBxmgvbOvoErOyWwMPgNzwtWNqEKruiEqgEjtQXCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-26","event_type":"agm_egm","title":"주주총회소집공고","reference":"20260225006062","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260225006062","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"YT9UULAf-MN5k_0WRyLDj64EHVSHQfHHI0TTX4bDwYBmV0sPPB_z58QjO-TocVCrmxiQJ60FUU_xtSBvY8qCDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-26","event_type":"corporate_news","title":"의결권대리행사권유참고서류","reference":"20260225006079","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260225006079","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4_aVLrLYeKOTTfbFRcTuSxWarzCxjNOvJF3RgIFHMsLLq9jSi_-_KavqFhRIa4Hbh3Ss44X-iouj2rcVxEp4BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-25","event_type":"agm_egm","title":"주주총회소집결의","reference":"20260225801897","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260225801897","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jjNUVhlHLg9ywYrsCWDcUMjRLtvavKeiuv8hGJjfk8kSl9zbdBqEJ9XRAPwHj_i4W5IC5_IWJkaNnSnBCGsWBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-25","event_type":"dividend","title":"현금ㆍ현물배당결정","reference":"20260225801979","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260225801979","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JnpkbVSqfP8wwnoCBQfOya6GxFr-yRtpvwfyuhRlvA-hitZNOWNx9H3PIFau01422mTl78l87uqbi7smn_FODQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-13","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등소유상황보고서","reference":"20260213002246","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260213002246","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 국민연금공단; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bGYxBV3wnfR56RTM9hAgoitcGMXwcGxc_vFLOg8f_aIt7mp8yDIQppw2MeophCWTbYGccIZk4K8CRZs6S99LAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-12","event_type":"corporate_news","title":"단일판매ㆍ공급계약해지","reference":"20260212801269","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260212801269","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5bkpU9ofhxJXjK_BsmBlxsz0PDDrerKXHKejdl3DE_sJ8GBoknathcuQTzBBtn-EMRAGR8KP9_-GaGLq5xDrDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-09","event_type":"results","title":"영업(잠정)실적(공정공시)","reference":"20260209800757","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260209800757","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Racz9ZcX7Qb8vwbE_9_H6OFMiApjApRnU-6DrZ0AFs79SIudJgf40hhV1Ufa3EuJ06vstfheZ_oDNN0oGmJPDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-02-09","event_type":"results","title":"매출액또는손익구조30%(대규모법인은15%)이상변경","reference":"20260209800722","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260209800722","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1huIGabhx7DwvvOlUN6OY_yqpPEatwPtuzd3YngJUxzUzYcomHTomzapubZuzlZQ-w6SUfLgxfm8GxJr555yAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-01-26","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등소유상황보고서","reference":"20260126000284","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260126000284","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 국민연금공단; corp_cls Y; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4RGD4qPmt6aw3nMj-i6gldGN0PX7WCA4wIOQJRPEwhOoZ1OU2Zoc_JmzXqfJvWqHDOPSL_L7OuruaqsLKhLSAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSPI/069620","date":"2026-01-23","event_type":"corporate_news","title":"투자판단관련주요경영사항","reference":"20260123800416","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260123800416","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 대웅제약; corp_cls Y; remarks 유","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aROg68-qBjsoApTkf6tjSS-OrS6iYaxTHUqnFphgUDUPTN-eQVXitE0bEDbQ5cHvwhLCjmdjgm32lkhxwXZ9CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}